(Q42952452)

English

A multicentre, open-label, randomized comparative study of tigecycline versus ceftriaxone sodium plus metronidazole for the treatment of hospitalized subjects with complicated intra-abdominal infections

scientific article published on August 1, 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

A multicentre, open-label, randomized comparative study of tigecycline versus ceftriaxone sodium plus metronidazole for the treatment of hospitalized subjects with complicated intra-abdominal infections (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

hospitalization

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

S. Towfigh

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20670293

13 June 2024

J. Pasternak

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20670293

13 June 2024

A. Poirier

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20670293

13 June 2024

H. Leister

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20670293

13 June 2024

T. Babinchak

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20670293

13 June 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20670293

13 June 2024

publication date

1 August 2010

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

full work available at URL

http://www.clinicalmicrobiologyandinfection.com/article/S1198743X14642300/pdf

Portable Document Format

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20670293

13 June 2024

https://api.elsevier.com/content/article/PII:S1198743X14642300?httpAccept=text/xml

1 reference

10.1111/J.1469-0691.2010.03122.X

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03122.X

13 June 2024

https://api.elsevier.com/content/article/PII:S1198743X14642300?httpAccept=text/plain

1 reference

10.1111/J.1469-0691.2010.03122.X

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03122.X

13 June 2024

Clinical Microbiology and Infection

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

16

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

1274-1281

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Update on antimicrobial susceptibility rates among gram-negative and gram-positive organisms in the United States: results from the Tigecycline Evaluation and Surveillance Trial (TEST) 2005 to 2007.

1

1 reference

10.1111/J.1469-0691.2010.03122.X

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03122.X

13 June 2024

Antimicrobial susceptibility among bacterial isolates from ICU and non-ICU setting and different age groups: results from the tigecycline evaluation and Surveillance trial in North America

2

1 reference

10.1111/J.1469-0691.2010.03122.X

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03122.X

13 June 2024

In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936).

3

1 reference

10.1111/J.1469-0691.2010.03122.X

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03122.X

13 June 2024

Rates of antimicrobial resistance in Latin America (2004-2007) and in vitro activity of the glycylcycline tigecycline and of other antibiotics

4

1 reference

10.1111/J.1469-0691.2010.03122.X

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03122.X

13 June 2024

Tigecycline is efficacious in the treatment of complicated intra-abdominal infections.

5

1 reference

10.1111/J.1469-0691.2010.03122.X

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03122.X

13 June 2024

A multicenter trial of the efficacy and safety of tigecycline versus imipenem/cilastatin in patients with complicated intra-abdominal infections [Study ID Numbers: 3074A1-301-WW; ClinicalTrials.gov Identifier: NCT00081744].

6

1 reference

10.1111/J.1469-0691.2010.03122.X

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03122.X

13 June 2024

Intra-abdominal infections

7

1 reference

10.1111/J.1469-0691.2010.03122.X

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03122.X

13 June 2024

Mortality for intra-abdominal infection is associated with intrinsic risk factors rather than the source of infection

8

1 reference

10.1111/J.1469-0691.2010.03122.X

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03122.X

13 June 2024

Prognosis in intra-abdominal infections. Multivariate analysis on 604 patients

9

1 reference

10.1111/J.1469-0691.2010.03122.X

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03122.X

13 June 2024

Effect of inappropriate initial empiric antibiotic therapy on outcome of patients with community-acquired intra-abdominal infections requiring surgery

10

1 reference

10.1111/J.1469-0691.2010.03122.X

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03122.X

13 June 2024

Review of the guidelines for complicated skin and soft tissue infections and intra-abdominal infections--are they applicable today?

11

1 reference

10.1111/J.1469-0691.2010.03122.X

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03122.X

13 June 2024

Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections.

12

1 reference

10.1111/J.1469-0691.2010.03122.X

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03122.X

13 June 2024

The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial data

13

1 reference

10.1111/J.1469-0691.2010.03122.X

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03122.X

13 June 2024

Identifiers

10.1111/J.1469-0691.2010.03122.X

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42952452&oldid=2178090626"